4.6 Article

Diverse, evolving conformer populations drive distinct phenotypes in frontotemporal lobar degeneration caused by the same MAPT-P301L mutation

Journal

ACTA NEUROPATHOLOGICA
Volume 139, Issue 6, Pages 1045-1070

Publisher

SPRINGER
DOI: 10.1007/s00401-020-02148-4

Keywords

Tauopathy; Aging; P301L mutation; Conformation; Focal pathology; Seeding; Strain ensembles; Transgenic mouse

Funding

  1. Canada Research Chair (Tier 1)
  2. CIHR [PS148962, GER 163048]
  3. Alberta Innovates Biosolutions [ABIBS AEP 201600021, 20160023, FP00209618]
  4. Canada Foundation for Innovation [NIF21633]
  5. CIHR CGS-M studentship
  6. NIH [1RF1AG058267, 1RF1AG061797]
  7. Alzheimer Society of Alberta through the joint Alberta Alzheimer's Research Program [AARP 201700005]
  8. Northwest Territories through the joint Alberta Alzheimer's Research Program [AARP 201700005]
  9. Alberta Synergies in Alzheimer's and Related Disorders (SynAD) program - Alzheimer Society of Alberta
  10. Northwest Territories through their Hope for Tomorrow program
  11. University Hospital Foundation
  12. Alberta Innovates [PEX19017]
  13. University of Alberta
  14. CONACYT [472481]

Ask authors/readers for more resources

Tau protein accumulation is a common denominator of major dementias, but this process is inhomogeneous, even when triggered by the same germline mutation. We considered stochastic misfolding of human tau conformers followed by templated conversion of native monomers as an underlying mechanism and derived sensitive conformational assays to test this concept. Assessments of brains from aged TgTau(P301L) transgenic mice revealed a prodromal state and three distinct signatures for misfolded tau. Frontotemporal lobar degeneration (FTLD)-MAPT-P301L patients with different clinical phenotypes also displayed three signatures, two resembling those found in TgTau(P301L) mice. As physicochemical and cell bioassays confirmed diverse tau strains in the mouse and human brain series, we conclude that evolution of diverse tau conformers is intrinsic to the pathogenesis of this uni-allelic form of tauopathy. In turn, effective therapeutic interventions in FTLD will need to address evolving repertoires of misfolded tau species rather than singular, static molecular targets.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available